Higher Risk of Death With Endocrine Therapy Nonadherence
Women with early-stage hormone receptor–positive breast cancer who do not adhere or persist with adjuvant endocrine therapy have a higher risk of relapse or mortality, a new analysis suggests.
Medscape Medical News
source https://www.medscape.com/viewarticle/994272?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/994272?src=rss
Comments
Post a Comment